Neogenomics posts $975K loss


  • By
  • | 2:59 p.m. November 1, 2012
  • Charlotte–Lee–Collier
  • Share

FORT MYERS — Cancer-testing firm Neogenomics posted a loss in the third quarter from a decrease in Medicare reimbursements and higher research and development expenses.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content